BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16789799)

  • 21. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zolmitriptan: a review of its use in migraine.
    Spencer CM; Gunasekara NS; Hills C
    Drugs; 1999 Aug; 58(2):347-74. PubMed ID: 10473025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eletriptan.
    Sandrini G; Perrotta A; Tassorelli C; Nappi G
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1587-98. PubMed ID: 19929447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eletriptan for acute migraine.
    Smith LA; Oldman AD; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2001; (3):CD003224. PubMed ID: 11687056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP; Gawel M
    Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
    Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
    Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
    Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
    Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
    Sandrini G; Färkkilä M; Burgess G; Forster E; Haughie S;
    Neurology; 2002 Oct; 59(8):1210-7. PubMed ID: 12391349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WITHDRAWN: Eletriptan for acute migraine.
    Smith LA; Oldman AD; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2007 Jul; 2001(1):CD003224. PubMed ID: 17636718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects.
    Kim YK; Shin KH; Alderman J; Yu KS; Jang IJ; Lee S
    Drug Des Devel Ther; 2018; 12():331-337. PubMed ID: 29497279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative aspects of triptans in treating migraine.
    Adelman JU; Lewit EJ
    Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review.
    Mathew NT; Hettiarachchi J; Alderman J
    Headache; 2003 Oct; 43(9):962-74. PubMed ID: 14511273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eletriptan in migraine.
    Diener HC
    Expert Rev Neurother; 2005 Jan; 5(1):43-53. PubMed ID: 15853473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Deleu D; Hanssens Y
    Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.
    Dodick DW; Sandrini G; Williams P
    CNS Drugs; 2007; 21(1):73-82. PubMed ID: 17190530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of zolmitriptan and its clinical applications in migraine.
    Dowson AJ; Charlesworth B
    Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rizatriptan: a review of its efficacy in the management of migraine.
    Dooley M; Faulds D
    Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.